Fibrinogen assay
|
phenotype |
|
Laboratory Procedure
|
55
|
143
|
0.100 |
None |
1.000 |
3 |
2
|
2013 |
2017 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
3
|
2018 |
2018 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Atherothrombosis
|
disease |
|
Acquired Abnormality
|
115
|
15
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Interleukin 1 Receptor-Like 1 Measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.020 |
None |
< 0.001 |
2 |
|
2003 |
2005 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Heart valve disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
79
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Aortic Aneurysm, Abdominal
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
586
|
90
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.320 |
None |
0.500 |
2 |
1
|
2005 |
2018 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Hepatolenticular Degeneration
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
146
|
349
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Behcet Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
502
|
243
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Gilles de la Tourette syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
177
|
63
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |